A VC's take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca

Retrieved on: 2023-01-10 23:15:49

Tags for this article:

Hypertension

Medicine

Medical specialties

Cardiovascular system

Interventional radiology

Renal sympathetic denervation

Management of hypertension

Antihypertensive drug

Click the tags to see associated articles and topics

A VC's take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca. View article details on hiswai: https://medcitynews.com/2023/01/a-vcs-take-on-the-1-3-billion-acquisition-of-cincor-pharma-by-astrazeneca/

Excerpt

Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring ...

Article found on: medcitynews.com

View Original Article